Skip to main content
Erschienen in: Endocrine 2/2011

01.10.2011 | Original Article

Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese

verfasst von: Chung-Huang Tsai, Tsai-Chung Li, Cheng-Chieh Lin, Hsin-Sheng Tsay

Erschienen in: Endocrine | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

To assess the clustering of modifiable cardiovascular risk factors among Taiwanese adults, we evaluated 579 healthy participants who underwent health examinations between May and December 2007. Exploratory factor analysis was used to examine risk factor clustering. Smoking, alcohol intake, exercise habits, body mass index, waist circumference, total cholesterol, triglycerides, high- and low-density lipoprotein cholesterol, fasting glucose, uric acid, serum hepatic enzymes, and mean arterial pressure were assessed. Separate factor analyses assessed total and low-density lipoprotein cholesterol. Principal components analysis identified five factors for a model without low-density lipoprotein cholesterol and four factors for a model without total cholesterol. Four common factors in both models explained between 51.1 and 51.8% of variance in the original 14 factors. Metabolic factors, hematological factors (white blood cells and platelets), lifestyle factors (smoking and alcohol consumption), and exercise habits and fasting blood glucose explained about 20, 11, 10, 10% of total variance, respectively. In the model without low-density lipoprotein cholesterol, total cholesterol factor explained 8.83% of variance. This study confirmed clustering of established metabolic syndrome components and revealed additional associated cardiovascular disease risk factors, including lifestyle factors, exercise and total cholesterol, which should be targeted in prevention efforts.
Literatur
1.
Zurück zum Zitat G.M. Reaven, Banting Lecture 1888. Role of insulin resistance in human disease. Diabetes 37(12), 1595–1607 (1988)PubMedCrossRef G.M. Reaven, Banting Lecture 1888. Role of insulin resistance in human disease. Diabetes 37(12), 1595–1607 (1988)PubMedCrossRef
2.
Zurück zum Zitat K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539–553 (1998)PubMedCrossRef K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539–553 (1998)PubMedCrossRef
3.
Zurück zum Zitat B. Balkau, M.A. Charles, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 16(5), 442–443 (1999)PubMedCrossRef B. Balkau, M.A. Charles, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 16(5), 442–443 (1999)PubMedCrossRef
4.
Zurück zum Zitat J.B. Meigs, Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol. 152(10), 908–911 (2000)PubMedCrossRef J.B. Meigs, Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am. J. Epidemiol. 152(10), 908–911 (2000)PubMedCrossRef
5.
Zurück zum Zitat P.A. Sakkinen, P. Wahl, M. Cushman, M.R. Lewis, R.P. Tracy, Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am. J. Epidemiol. 152(10), 897–907 (2000)PubMedCrossRef P.A. Sakkinen, P. Wahl, M. Cushman, M.R. Lewis, R.P. Tracy, Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am. J. Epidemiol. 152(10), 897–907 (2000)PubMedCrossRef
6.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285(19), 2486–2497 (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285(19), 2486–2497 (2001)
7.
Zurück zum Zitat D. Einhorn, G.M. Reaven, R.H. Cobin, E. Ford, O.P. Ganda, Y. Handelsman, R. Hellman, P.S. Jellinger, D. Kendall, R.M. Krauss, N.D. Neufeld, S.M. Petak, H.W. Rodbard, J.A. Seibel, D.A. Smith, P.W. Wilson, American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9(3), 237–252 (2003)PubMed D. Einhorn, G.M. Reaven, R.H. Cobin, E. Ford, O.P. Ganda, Y. Handelsman, R. Hellman, P.S. Jellinger, D. Kendall, R.M. Krauss, N.D. Neufeld, S.M. Petak, H.W. Rodbard, J.A. Seibel, D.A. Smith, P.W. Wilson, American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9(3), 237–252 (2003)PubMed
8.
Zurück zum Zitat R. Kahn, J. Buse, E. Ferrannini, M. Stern, The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9), 2289–2304 (2005)PubMedCrossRef R. Kahn, J. Buse, E. Ferrannini, M. Stern, The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9), 2289–2304 (2005)PubMedCrossRef
9.
Zurück zum Zitat S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.I. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. SPertus, F. Costa, American Heart Association/National Heart, Lung and Blood Institute, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lund and Blood Institute Scientific Statement. Circulation 112, 2735–2752 (2005)PubMedCrossRef S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.I. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. SPertus, F. Costa, American Heart Association/National Heart, Lung and Blood Institute, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lund and Blood Institute Scientific Statement. Circulation 112, 2735–2752 (2005)PubMedCrossRef
10.
Zurück zum Zitat L.W. Johnson, R.S. Weinstock, The metabolic syndrome: concepts and controversy. Mayo Clin. Proc. 81(12), 1615–1620 (2006)PubMedCrossRef L.W. Johnson, R.S. Weinstock, The metabolic syndrome: concepts and controversy. Mayo Clin. Proc. 81(12), 1615–1620 (2006)PubMedCrossRef
11.
Zurück zum Zitat C. Tsai, S. Huang, K. Lin, The study of the metabolic syndrome and its relevant factors—data analysis of health examination. Chin. J. Fam. Med. 16, 84–94 (2006) C. Tsai, S. Huang, K. Lin, The study of the metabolic syndrome and its relevant factors—data analysis of health examination. Chin. J. Fam. Med. 16, 84–94 (2006)
12.
Zurück zum Zitat N. Nakanishi, K. Suzuki, K. Tatara, Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27(6), 1427–1432 (2004)PubMedCrossRef N. Nakanishi, K. Suzuki, K. Tatara, Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27(6), 1427–1432 (2004)PubMedCrossRef
13.
Zurück zum Zitat L.K. Niskanen, D.E. Laaksonen, K. Nyyssönen, G. Alfthan, H.M. Lakka, T.A. Lakka, J.T. Salonen, Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch. Intern. Med. 164(14), 1546–1551 (2004)PubMedCrossRef L.K. Niskanen, D.E. Laaksonen, K. Nyyssönen, G. Alfthan, H.M. Lakka, T.A. Lakka, J.T. Salonen, Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch. Intern. Med. 164(14), 1546–1551 (2004)PubMedCrossRef
14.
Zurück zum Zitat K. Sudi, S. Gallistl, D. Payerl, R. Aigner, R. Möller, E. Tafeit, M.H. Borkenstein, Interrelationship between estimates of adiposity and body fat distribution with metabolic and hemostatic parameters in obese children. Metabolism 50(6), 681–687 (2001)PubMedCrossRef K. Sudi, S. Gallistl, D. Payerl, R. Aigner, R. Möller, E. Tafeit, M.H. Borkenstein, Interrelationship between estimates of adiposity and body fat distribution with metabolic and hemostatic parameters in obese children. Metabolism 50(6), 681–687 (2001)PubMedCrossRef
15.
Zurück zum Zitat B.J. Shen, J.F. Todaro, R. Niaura, J.M. McCaffery, J. Zhang, A. Spiro 3rd, K.D. Ward, Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am. J. Epidemiol. 157(8), 701–711 (2003)PubMedCrossRef B.J. Shen, J.F. Todaro, R. Niaura, J.M. McCaffery, J. Zhang, A. Spiro 3rd, K.D. Ward, Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am. J. Epidemiol. 157(8), 701–711 (2003)PubMedCrossRef
16.
Zurück zum Zitat S.Y. Chuang, C.H. Chen, P. Chou, Hypertension and the insulin-related metabolic syndrome: factor analysis in 17, 539 Taiwanese. Acta Cardiol. Sin. 20, 229–236 (2004) S.Y. Chuang, C.H. Chen, P. Chou, Hypertension and the insulin-related metabolic syndrome: factor analysis in 17, 539 Taiwanese. Acta Cardiol. Sin. 20, 229–236 (2004)
17.
Zurück zum Zitat F. Leyva, I.F. Godsland, M. Worthington, C. Walton, J.C. Stevenson, Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler. Thromb. Vasc. Biol. 18(2), 208–214 (1998)PubMedCrossRef F. Leyva, I.F. Godsland, M. Worthington, C. Walton, J.C. Stevenson, Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler. Thromb. Vasc. Biol. 18(2), 208–214 (1998)PubMedCrossRef
18.
Zurück zum Zitat C. Snehalatha, S. Sivasankari, K. Satyavani, V. Vijay, A. Ramachandran, Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet. Med. 17(2), 152–157 (2000)PubMedCrossRef C. Snehalatha, S. Sivasankari, K. Satyavani, V. Vijay, A. Ramachandran, Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet. Med. 17(2), 152–157 (2000)PubMedCrossRef
19.
Zurück zum Zitat T.L. Liou, M.W. Lin, L.C. Hsiao, T.T. Tsai, W.L. Chan, L.T. Ho, C.M. Hwu, Is hyperuricemia another facet of the metabolic syndrome? J. Chin. Med. Assoc. 69(3), 104–109 (2006)PubMedCrossRef T.L. Liou, M.W. Lin, L.C. Hsiao, T.T. Tsai, W.L. Chan, L.T. Ho, C.M. Hwu, Is hyperuricemia another facet of the metabolic syndrome? J. Chin. Med. Assoc. 69(3), 104–109 (2006)PubMedCrossRef
20.
Zurück zum Zitat K.M. Choi, J. Lee, K.B. Kim, D.R. Kim, S.K. Kim, D.H. Shin, N.H. Kim, I.B. Park, D.S. Choi, S.H. Baik, Factor analysis of the metabolic syndrome among elderly Koreans—the South-west Seoul Study. Diabet. Med. 20(2), 99–104 (2003)PubMedCrossRef K.M. Choi, J. Lee, K.B. Kim, D.R. Kim, S.K. Kim, D.H. Shin, N.H. Kim, I.B. Park, D.S. Choi, S.H. Baik, Factor analysis of the metabolic syndrome among elderly Koreans—the South-west Seoul Study. Diabet. Med. 20(2), 99–104 (2003)PubMedCrossRef
21.
Zurück zum Zitat S. Yusuf, S. Reddy, S. Ounpuu, S. Anand, Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104(23), 2855–2864 (2001)PubMedCrossRef S. Yusuf, S. Reddy, S. Ounpuu, S. Anand, Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104(23), 2855–2864 (2001)PubMedCrossRef
22.
Zurück zum Zitat F. Hadaegh, H. Harati, A. Ghanbarian, F. Azizi, Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur. J. Cardiovasc. Prev. Rehabil. 13(4), 571–577 (2006)PubMedCrossRef F. Hadaegh, H. Harati, A. Ghanbarian, F. Azizi, Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur. J. Cardiovasc. Prev. Rehabil. 13(4), 571–577 (2006)PubMedCrossRef
23.
Zurück zum Zitat J. Ohrvik, P. Hedberg, T. Jonason, I. Lonnberg, G. Nilsson, Factor analysis of the individual components of the metabolic syndrome among elderly identifies two factors with different survival patterns—a population-based study. Metab. Syndr. Relat. Disord. 7, 171–177 (2009)PubMedCrossRef J. Ohrvik, P. Hedberg, T. Jonason, I. Lonnberg, G. Nilsson, Factor analysis of the individual components of the metabolic syndrome among elderly identifies two factors with different survival patterns—a population-based study. Metab. Syndr. Relat. Disord. 7, 171–177 (2009)PubMedCrossRef
24.
Zurück zum Zitat A.J. Hanley, A.J. Karter, A. Festa, R. D’Agostino Jr., L.E. Wagenknecht, P. Savage, R.P. Tracy, M.F. Saad, S. Haffner, Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51(8), 2642–2647 (2002)PubMedCrossRef A.J. Hanley, A.J. Karter, A. Festa, R. D’Agostino Jr., L.E. Wagenknecht, P. Savage, R.P. Tracy, M.F. Saad, S. Haffner, Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51(8), 2642–2647 (2002)PubMedCrossRef
25.
Zurück zum Zitat C.Z. Wu, J.D. Lin, J.C. Li, F.C. Hsiao, S.W. Kuo, Yi Hung, C.H. Lu, C.T. He, D. Pei, Factor analysis of metabolic syndrome using direct measurement of insulin resistance in Chinese with different degrees of glucose tolerance. Indian J. Med. Res. 127(4), 336–343 (2008)PubMed C.Z. Wu, J.D. Lin, J.C. Li, F.C. Hsiao, S.W. Kuo, Yi Hung, C.H. Lu, C.T. He, D. Pei, Factor analysis of metabolic syndrome using direct measurement of insulin resistance in Chinese with different degrees of glucose tolerance. Indian J. Med. Res. 127(4), 336–343 (2008)PubMed
26.
Zurück zum Zitat A. Bener, M. Zirie, M. Musallam, Y.S. Khader, A.O. Al-Hamaq, Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab. Syndr. Relat. Disord. 7, 221–229 (2009)PubMedCrossRef A. Bener, M. Zirie, M. Musallam, Y.S. Khader, A.O. Al-Hamaq, Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab. Syndr. Relat. Disord. 7, 221–229 (2009)PubMedCrossRef
27.
Zurück zum Zitat R.M. Mabry, M.M. Reeves, E.G. Eakin, N. Owen, Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet. Med. 27, 593–597 (2010)PubMedCrossRef R.M. Mabry, M.M. Reeves, E.G. Eakin, N. Owen, Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet. Med. 27, 593–597 (2010)PubMedCrossRef
28.
Zurück zum Zitat L.C. Hwang, C.H. Bai, C.J. Chen, K.L. Chien, Gender differences on the development of metabolic syndrome: a population-based study in Taiwan. Eur. J. Epidemiol. 22, 899–906 (2007)PubMedCrossRef L.C. Hwang, C.H. Bai, C.J. Chen, K.L. Chien, Gender differences on the development of metabolic syndrome: a population-based study in Taiwan. Eur. J. Epidemiol. 22, 899–906 (2007)PubMedCrossRef
29.
Zurück zum Zitat Y.C. Chen, H.P. Wu, S.J. Hwang, I.C. Li, Exploring the components of metabolic syndrome with respect to gender difference and its relationship to health-promoting lifestyle behaviour: a study in Taiwanese urban communities. J. Clin. Nurs. 19, 3031–3041 (2010)PubMedCrossRef Y.C. Chen, H.P. Wu, S.J. Hwang, I.C. Li, Exploring the components of metabolic syndrome with respect to gender difference and its relationship to health-promoting lifestyle behaviour: a study in Taiwanese urban communities. J. Clin. Nurs. 19, 3031–3041 (2010)PubMedCrossRef
30.
Zurück zum Zitat D.A. Lawlor, S. Ebrahim, M. May, G. Davey Smith, (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 159(11), 1013–1018 (2004)PubMedCrossRef D.A. Lawlor, S. Ebrahim, M. May, G. Davey Smith, (Mis)use of factor analysis in the study of insulin resistance syndrome. Am. J. Epidemiol. 159(11), 1013–1018 (2004)PubMedCrossRef
31.
Zurück zum Zitat A. Gupta, V. Gupta, Metabolic syndrome: what are the risks for humans? Biosci. Trends 4, 204212 (2010) A. Gupta, V. Gupta, Metabolic syndrome: what are the risks for humans? Biosci. Trends 4, 204212 (2010)
32.
Zurück zum Zitat R.K. Schindheim, M. Diamant, J.M. Dekker, M.E. Tushuizen, T. Teerlink, R.J. Heine, Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab. Res. Rev. 22, 437–443 (2006)CrossRef R.K. Schindheim, M. Diamant, J.M. Dekker, M.E. Tushuizen, T. Teerlink, R.J. Heine, Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab. Res. Rev. 22, 437–443 (2006)CrossRef
33.
Zurück zum Zitat R.L. Borges, A.B. Ribeiro, M.T. Zanella, M.C. Batista, Uric acid as a factor in the metabolic syndrome. Curr. Hypertens. Rep. 12, 113–119 (2010)PubMedCrossRef R.L. Borges, A.B. Ribeiro, M.T. Zanella, M.C. Batista, Uric acid as a factor in the metabolic syndrome. Curr. Hypertens. Rep. 12, 113–119 (2010)PubMedCrossRef
34.
Zurück zum Zitat M. Alderman, K.J. Aiyer, Uric acid: role in cardiovascular disease and effects of Iosartan. Curr. Med. Res. Opin. 20, 369–379 (2004)PubMedCrossRef M. Alderman, K.J. Aiyer, Uric acid: role in cardiovascular disease and effects of Iosartan. Curr. Med. Res. Opin. 20, 369–379 (2004)PubMedCrossRef
Metadaten
Titel
Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese
verfasst von
Chung-Huang Tsai
Tsai-Chung Li
Cheng-Chieh Lin
Hsin-Sheng Tsay
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2011
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9466-1

Weitere Artikel der Ausgabe 2/2011

Endocrine 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.